XXII
22nd Century Group, Inc.
NASDAQ · Consumer Defensive · Tobacco · US
$0.27
+2.13%Year over year
Reported trailing growth
- Revenue
- +7.4%
- EBITDA
- +4.6%
- EBIT
- +6.3%
- EPS
- +92.1%
- Free cash flow
- +40.2%
- Operating cash flow
- +39.5%
Forward estimates
Based on analyst estimates
- Revenue
- +26.0%
- EBITDA
- +135.1%
- EPS
- +113.1%
Three-year CAGR
- Revenue
- -44.2%
- EBITDA
- +13.0%
- EBIT
- +18.2%
- Net income
- +66.7%
- EPS
- +99.9%
- Free cash flow
- +40.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026